E. coli bacteria can be used to create low cost COVID vaccines. A study on mice using a novel liposomal adjuvant shows the vaccine induced polyclonal antibodies in vitro, and potently neutralized homologous and heterologous SARS-CoV-2 pseudoviruses. mdpi.com Submitted by glawgii t3_zvgatz on December 26, 2022 at 5:49 AM in science 14 comments 399
GeoffLizzard t1_j1pq2xn wrote on December 26, 2022 at 11:54 AM Oh, so the hemondungytes of the virus are poroferous with vitro-heptalization? Interesting, i never thought metaviruses in the SARS-Cov-2 strain had prolagillian amobdeni! This will be groundbreaking! Permalink −8−
Viewing a single comment thread. View all comments